Lexaria Bioscience Corp. (LEXX)

CIK 1348362 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lexaria Bioscience Corp..

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001640334-26-001468
Sep 1, 20268-K0001640334-26-001437
Aug 17, 20268-K0001640334-26-001384
Aug 10, 20268-K0001640334-26-001302
Jul 30, 20268-K0001640334-26-001258
Jul 13, 202610-Q0001640334-26-001166
Apr 13, 202610-Q0001640334-26-000687
Mar 18, 202640001103780-26-000001
Feb 6, 20268-K0001640334-26-000230
Jan 28, 2026S-80001640334-26-000159
Jan 28, 20268-K0001640334-26-000162
Jan 14, 2026424B30001640334-26-000089
Jan 14, 202625-NSE0001354457-26-000039
Jan 14, 2026EFFECT9999999995-26-000171
Jan 13, 202610-Q0001640334-26-000080
Dec 29, 2025S-30001640334-25-002382
Dec 19, 2025D0001348362-25-000018
Dec 16, 2025424B50001640334-25-002331
Dec 16, 20258-K0001640334-25-002348
Dec 10, 2025DEF 14A0001640334-25-002275
Dec 9, 2025EFFECT9999999995-25-003607
Dec 9, 2025424B30001640334-25-002271
Dec 8, 2025EFFECT9999999995-25-003563
Dec 5, 2025POS AM0001640334-25-002260
Dec 5, 2025S-1/A0001640334-25-002256